- freely available
In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments
AbstractSingle chain variable domain (Fv) fragments (scFv) are powerful tools in research and clinical settings, owing to better pharmacokinetic properties compared to the parent monoclonal antibodies and the relative ease of producing them in large quantities, at low cost. Though they offer several advantages, they suffer from lower binding affinity and rapid clearance from circulation, which limits their therapeutic potential. However, these fragments can be genetically modified to enhance desirable properties, such as multivalency, high target retention and slower blood clearance, and as such, a variety of scFv formats have been generated. ScFvs can be administered by systemic injection for diagnostic and therapeutic purposes. They can be expressed in vivo through viral vectors in instances where large infection rates and sustenance of high levels of the antibody is required. ScFvs have found applications as tools for in vivo loss-of-function studies and inactivation of specific protein domains, diagnostic imaging, tumor therapy and treatment for neurodegenerative and infectious diseases. This review will focus on their in vivo applications.
Share & Cite This Article
Monnier, P.P.; Vigouroux, R.J.; Tassew, N.G. In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies 2013, 2, 193-208.View more citation formats
Monnier PP, Vigouroux RJ, Tassew NG. In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments. Antibodies. 2013; 2(2):193-208.Chicago/Turabian Style
Monnier, Philippe P.; Vigouroux, Robin J.; Tassew, Nardos G. 2013. "In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments." Antibodies 2, no. 2: 193-208.
Notes: Multiple requests from the same IP address are counted as one view.